Other News

XyloCor Therapeutics Achieves Target Enrollment in Phase 2 EXACT Study of XC001 Novel Gene Therapy for Ischemic Heart Disease

Positive Phase 1 results reported at the American Association for Thoracic Surgery (AATS) and the American Society of Gene and Cell Therapy (ASGCT) revealed XC001 is well tolerated at all dose levels Phase I data support XC001 therapeutic effect and potential dose response Topline Phase 2 data readout expected in […]

Acutus Medical Announces FDA Clearance, Commercial Launch of AcQCross™ Line Extension Compatible with Watchman™ Delivery System

Innovative Transseptal Access System Is First and Only to Feature Integrated Dilator and Needle to Reduce Exchanges CARLSBAD, Calif., June 27, 2022 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced the commercial […]

Centerline Biomedical Raises $33 Million in Series B Financing

Proceeds will accelerate a robust R&D pipeline, commercial partnerships and clinical activities led by leading institutional and strategic investors CLEVELAND, June 27, 2022 /PRNewswire/ — Centerline Biomedical, Inc. (Centerline), a private medical technology company, announced the closing of a $33 million Series B equity financing led by Cleveland Clinic with participation by GE Healthcare, […]

Humacyte Expands Board of Directors with Appointment of Diane Seimetz, Ph.D.

Industry leader brings deep expertise in international drug development, strategic leadership, and corporate partnering for biopharmaceutical companies DURHAM, N.C., June 27, 2022 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today announced the appointment of Diane Seimetz, […]

Quantum Genomics announces the appointment of its new Scientific Advisory Board

PARIS, June 27, 2022 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specializing in the development of a new drug class directly targeting the brain to treat hypertension and heart failure, today announces the appointment of new members of its Scientific Advisory Board. Professor George L. Bakris […]

Health Canada Approves Penumbra’s RED Reperfusion Catheters

News from Penumbra Inc. June 23, 2022 ALAMEDA, Calif.–Penumbra Inc. (NYSE: PEN) shared that its latest RED Reperfusion Catheters received approval from Health Canada, expanding on the company’s extensive portfolio of innovative stroke products in Canada. The RED Catheters are designed with optimized trackability to help navigate the complex distal vessel anatomy […]

BayCare Receives Recognition for its Minimally Invasive Transcatheter Valve Procedures

CLEARWATER, Fla., June 23, 2022 /PRNewswire/ — The structural heart programs at BayCare’s Morton Plant Hospital in Clearwater and St. Joseph’s Hospital in Tampa recently received the American College of Cardiology (ACC) Transcatheter Valve Certification. The certification recognizes each program’s expertise and commitment to excellence in treating patients receiving transcatheter valve repair and replacement procedures. “Our […]

Liquidia Corporation Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

MORRISVILLE, N.C., June 24, 2022 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) today announced the grant of an inducement stock option exercisable for 2,000 shares of Liquidia’s common stock to a newly hired non-executive employee under the Liquidia Corporation 2022 Inducement Plan (the “Inducement Plan”). The stock option was granted […]